Institutional Overview
About
Manna Corp is a U.S.-based organization that operates independent clinical software and therapeutic development programs under unified corporate governance.
What We Do
V2
A standalone clinical software platform for healthcare providers focused on care coordination, data integrity, and operational clarity.
Cancer Immunotherapy Program
An independent cancer immunotherapy research and development effort conducted under standard scientific and regulatory frameworks.
These initiatives are operationally separate and do not share technical, developmental, or clinical dependencies.
How We Operate
Our work is governed by fixed operating principles that guide decision-making across programs.
Operating Principles
Stewardship Before Scale
We prioritize long-term responsibility over rapid expansion.
Simplicity as a Requirement
Systems must remain clear, traceable, and usable under pressure.
Truth Without Distortion
Data, outcomes, and decisions are represented accurately and without narrative bias.
Human Life as the Constraint
Every system and program is designed with dignity, safety, and respect as fixed boundaries.
Open and Ethical Collaboration
We support interoperability and responsible access that strengthen care without exploiting it.
Governance
Manna Corp operates under formal corporate governance with independent oversight.
Each initiative functions within its own regulatory and operational framework. Corporate leadership provides stewardship, risk management, and long-term direction while preserving program independence.
Leadership
Skylar Carver
Board Chairman & CEO
Randall Hubbard, PhD
Board Member
Colleen McLaughlin, PhD
Board Member
Closing
Manna Corp exists to support medicine that can be trusted.
We design systems clinicians can rely on.
We develop programs that respect patients.
Regulatory Position
Manna Corp develops software and investigational therapies under established scientific and regulatory frameworks.
Website content is informational and does not constitute medical or clinical guidance.